Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Applying medicinal chemistry strategies to understand odorant discrimination.

Poivet E, Peterlin Z, Tahirova N, Xu L, Altomare C, Paria A, Zou DJ, Firestein S.

Nat Commun. 2016 Apr 4;7:11157. doi: 10.1038/ncomms11157.

2.

Treating Diabetes Mellitus: Pharmacophore Based Designing of Potential Drugs from Gymnema sylvestre against Insulin Receptor Protein.

Hossain MU, Khan MA, Rakib-Uz-Zaman SM, Ali MT, Islam MS, Keya CA, Salimullah M.

Biomed Res Int. 2016;2016:3187647. doi: 10.1155/2016/3187647. Epub 2016 Feb 28.

3.

A Comparative Study of Molecular Structure, pKa, Lipophilicity, Solubility, Absorption and Polar Surface Area of Some Antiplatelet Drugs.

Remko M, Remková A, Broer R.

Int J Mol Sci. 2016 Mar 19;17(3). pii: E388. doi: 10.3390/ijms17030388.

4.

Structuprint: a scalable and extensible tool for two-dimensional representation of protein surfaces.

Kontopoulos DG, Vlachakis D, Tsiliki G, Kossida S.

BMC Struct Biol. 2016 Feb 24;16(1):4. doi: 10.1186/s12900-016-0055-7. Erratum in: BMC Struct Biol. 2016;16(1):6.

5.

Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus.

Karthick V, Nagasundaram N, Doss CG, Chakraborty C, Siva R, Lu A, Zhang G, Zhu H.

Infect Dis Poverty. 2016 Feb 17;5(1):12. doi: 10.1186/s40249-016-0105-1.

6.

Efficient one-pot synthesis, molecular docking and in silico ADME prediction of bis-(4-hydroxycoumarin-3-yl) methane derivatives as antileishmanial agents.

Zaheer Z, Khan FA, Sangshetti JN, Patil RH.

EXCLI J. 2015 Aug 10;14:935-47. doi: 10.17179/excli2015-244. eCollection 2015.

7.

Improving quantitative structure-activity relationship models using Artificial Neural Networks trained with dropout.

Mendenhall J, Meiler J.

J Comput Aided Mol Des. 2016 Feb;30(2):177-89. doi: 10.1007/s10822-016-9895-2. Epub 2016 Feb 1.

PMID:
26830599
8.

Insights from the molecular docking of curcumin to the virulent factors of Helicobacter pylori.

Srivastava AK, Kumar V, Roy BK.

Bioinformation. 2015 Oct 31;11(10):447-53. doi: 10.6026/97320630011447. eCollection 2015.

9.

Design, synthesis and anticonvulsant activity of some new 5,7-dibromoisatin semicarbazone derivatives.

Kumar D, Sharma VK, Kumar R, Singh T, Singh H, Singh AD, Roy RK.

EXCLI J. 2013 Jul 11;12:628-40. eCollection 2013.

10.

Crystal structure of (E)-4-[N-(7-methyl-2-phenyl-imidazo[1,2-a]pyridin-3-yl)carboximido-yl]phenol.

Elaatiaoui A, Saddik R, Benchat N, Saadi M, El Ammari L.

Acta Crystallogr E Crystallogr Commun. 2015 Sep 30;71(Pt 10):o803-4. doi: 10.1107/S2056989015017843. eCollection 2015 Oct 1.

11.

Novel coumarin-benzimidazole derivatives as antioxidants and safer anti-inflammatory agents.

Arora RK, Kaur N, Bansal Y, Bansal G.

Acta Pharm Sin B. 2014 Oct;4(5):368-75. doi: 10.1016/j.apsb.2014.07.001. Epub 2014 Aug 10.

12.

Antibacterial Derivatives of Ciprofloxacin to Inhibit Growth of Necrotizing Fasciitis Associated Penicillin Resistant Escherichia coli.

Bartzatt R, Cirillo SL, Cirillo JD.

J Pharm (Cairo). 2013;2013:517638. doi: 10.1155/2013/517638. Epub 2013 May 2.

13.

Design, synthesis, and antitumor evaluation of histone deacetylase inhibitors with L-phenylglycine scaffold.

Zhang Y, Li X, Hou J, Huang Y, Xu W.

Drug Des Devel Ther. 2015 Oct 8;9:5553-67. doi: 10.2147/DDDT.S94037. eCollection 2015.

14.

The supramolecular chemistry of lipid oxidation and antioxidation in bulk oils.

Budilarto ES, Kamal-Eldin A.

Eur J Lipid Sci Technol. 2015 Aug;117(8):1095-1137. Epub 2015 Feb 26. Review.

15.

iPPI-DB: an online database of modulators of protein-protein interactions.

Labbé CM, Kuenemann MA, Zarzycka B, Vriend G, Nicolaes GA, Lagorce D, Miteva MA, Villoutreix BO, Sperandio O.

Nucleic Acids Res. 2016 Jan 4;44(D1):D542-7. doi: 10.1093/nar/gkv982. Epub 2015 Oct 1.

17.

2-Allylaminothiazole and 2-allylaminodihydrothiazole derivatives: synthesis, characterization, and evaluation of bioactivity.

Studzińska R, Karczmarska-Wódzka A, Kozakiewicz A, Kołodziejska R, Paprocka R, Wróblewski M, Augustyńska B, Modzelewska-Banachiewicz B.

Monatsh Chem. 2015;146(10):1673-1679. Epub 2015 Aug 5.

18.

Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.

Young EJ, Blouin AM, Briggs SB, Sillivan SE, Lin L, Cameron MD, Rumbaugh G, Miller CA.

Mol Psychiatry. 2016 May;21(5):615-23. doi: 10.1038/mp.2015.103. Epub 2015 Aug 4.

PMID:
26239291
19.

Quantitative Structure-Antioxidant Activity Models of Isoflavonoids: A Theoretical Study.

Castellano G, Torrens F.

Int J Mol Sci. 2015 Jun 8;16(6):12891-906. doi: 10.3390/ijms160612891.

20.

Application of RNAi to Genomic Drug Target Validation in Schistosomes.

Guidi A, Mansour NR, Paveley RA, Carruthers IM, Besnard J, Hopkins AL, Gilbert IH, Bickle QD.

PLoS Negl Trop Dis. 2015 May 20;9(5):e0003801. doi: 10.1371/journal.pntd.0003801. eCollection 2015 May.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk